Logo.png
Cocrystal to Present at the 3rd Annual reimagine Health Research Symposium
January 14, 2021 08:00 ET | Cocrystal Pharma, Inc.
BOTHELL, Wash., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
Logo.png
Cocrystal Pharma to Present at Virtual NobleCon17 Conference on January 19, 2021
January 12, 2021 08:00 ET | Cocrystal Pharma, Inc.
BOTHELL, Wash., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
CocrystalPharmaInc.jpg
Cocrystal Pharma Increases Previously Announced Bought Deal to $15.0 Million
August 26, 2020 22:00 ET | Cocrystal Pharma, Inc.
BOTHELL, WA, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel...
CocrystalPharmaInc.jpg
Cocrystal Pharma Reports Second Quarter 2020 Financial Results and Provides Updates on Antiviral Programs
August 06, 2020 08:05 ET | Cocrystal Pharma, Inc.
– COVID-19 program in preclinical development; Discussions with potential strategic partners ongoing – – Merck collaboration to discover and develop influenza A/B antiviralagents progresses – ...
CocrystalPharmaInc.jpg
Cocrystal Pharma Announces Appointment of Nobel Laureate and Scientific Advisor, Roger D. Kornberg, Ph.D., to Board of Directors
April 20, 2020 08:05 ET | Cocrystal Pharma, Inc.
- Work completed over decades of renowned biochemist’s career serves as basis for Company’s structure-based technology which has demonstrated broad utility in development of proprietary antivirals - ...
CocrystalPharmaInc.jpg
Cocrystal Pharma to Present at the April 2020 Virtual Investor Summit
April 15, 2020 08:05 ET | Cocrystal Pharma, Inc.
– Presentation with live audio webcast on Wednesday, April 22 at 11:00 AM ET, immediately followed by an interactive Q&A session – BOTHELL, WA,, April 15, 2020 (GLOBE NEWSWIRE) -- Cocrystal...
CocrystalPharmaInc.jpg
Cocrystal Pharma Announces $6.8 Million Registered Direct Offering Priced At-the-Market
March 09, 2020 15:00 ET | Cocrystal Pharma, Inc.
BOTHELL, WA, March 09, 2020 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel...
CocrystalPharmaInc.jpg
Cocrystal Pharma Announces Plans to Advance Coronavirus Program
March 06, 2020 16:01 ET | Cocrystal Pharma, Inc.
Company has immediately initiated Coronavirus programLeveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”) Strong financial position bolsters Company’s...
CocrystalPharmaInc.jpg
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
February 28, 2020 14:00 ET | Cocrystal Pharma, Inc.
BOTHELL, WA, Feb. 28, 2020 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral...
CocrystalPharmaInc.jpg
Cocrystal Pharma Announces $11.0 Million Registered Direct Offering Priced At-the-Market
February 27, 2020 07:00 ET | Cocrystal Pharma, Inc.
BOTHELL, WA, Feb. 27, 2020 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral...